NewInsight: Anthropic's IPO in charts

West Pharmaceutical Services WST

West Pharmaceutical Services is the 335th largest S&P 500 company by market cap, worth $28.8 billion. Its board has 14 directors, 10 of them independent. 8 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 13.3% of the company.

Chair
Eric Mark Green
Sector
Health CareHealth Care Supplies
Headquarters
Exton, Pennsylvania
Founded
1923
Market cap
$28.8B
335th largest, 11 Nov 2026 close
Revenue
$3.1B
Fiscal year 2025
Price to sales
9.4
Market cap over revenue
Employees
10,800
10-K, 31 Dec 2025
Per employee
$2.7M
Market cap over employees
Connections
4
Companies sharing people

Financials

Latest quarter

Q2 2026 figures from West Pharmaceutical Services' earnings release.

Filed 23 Jul 2026

Revenue
$872M
Up 14% year over year
Net income
$154M
Up 17% year over year
Diluted EPS
$2.15
Up 18% year over year
Operating income
$179M
Up 17% year over year

Reported figures

Figures from the release, against the same period a year earlier.

FigureValueYear earlierChange
Net sales$872M$767M+14%
Diluted EPS$2.15$1.82+18%
Adjusted-diluted EPS$2.37$1.84+29%
Operating cash flow$214M--
Capital expenditures$86M--
Free cash flow$128M--
Gross profit$329M$274M+20%
Operating profit$179M$154M+17%
Net income$154M$132M+17%
Gross profit margin37.7%35.7%+2.0 pts
Reported Operating Profit Margin20.5%20.1%+0.4 pts
Adjusted Operating Profit$197M$155M+27%
Adjusted Operating Profit Margin22.6%20.3%+2.3 pts

Financial history

Twelve months to 30 Sep 2026, from West Pharmaceutical Services' quarterly filings.

Quarters since Dec 2021

Revenue
$3.4B
Up 13% on the year before
Net income
$639M
18.8% of revenue
Free cash flow
$453M
Operating cash flow less capital spending
P/E
45.0
Market cap over net income

Quarterly results

Each quarter's revenue, net income and free cash flow.

Dec 2021 to Sep 2026

$0$250M$500M$750M$1B202120222023202420252026$875M

Per employee

Twelve months to 30 Sep 2026, over 10,800 employees in West Pharmaceutical Services' latest 10-K.

Revenue
$315K
Operating profit
$72K
23.0% of revenue
Net income
$59K
18.8% of revenue

Revenue breakdown

West Pharmaceutical Services' $875M of revenue, as its quarterly report splits it. Parts that are not a business, such as sales between segments, can be negative.

Quarter to Sep 2026

  • Proprietary Products$729M, 83.3%
  • West Vantage$146M, 16.7%

West Pharmaceutical Services' market cap since December 2008

Weekly, up to 6 Nov 2026

Show equal percentage changes as equal steps.
201020122014201620182020202220242026$27.9B

Board and leadership

Board and officers

4 people here also hold roles at other S&P 500 companies.

Board from the proxy filed 12 Mar 2026; officers filed up to 30 Sep 2026

NameTitleSinceIndependentCommitteesAge
Directors (14)
Eric Mark GreenChair and CEONot independent · since 2015Also at EcolabChair and CEO2015No56
Mark A. ButhmanDirectorIndependent · since 2011 · CompensationFormer Executive Vice President & Chief Financial Officer, Kimberly-Clark CorporationAlso at IDEXDirector2011YesCompensation65
William F. FeeheryDirectorDirector
William F. Feehery, Ph.D.DirectorIndependent · since 2012 · AuditFormer Chief Executive Officer, Certara, Inc.Director2012YesAudit56
Robert F. FrielLead Independent DirectorIndependent · since 2020 · Nominating and Corporate GovernanceRetired Chair, President & Chief Executive Officer, PerkinElmer, Inc. (now Revvity, Inc.)Also at XylemLead Independent Director2020YesNominating and Corporate Governance70
Janet Brutschea HaugenDirectorIndependent · since 2024 · Audit (chair)Retired Chief Financial Officer, Unisys CorporationOther boards: Bentley Systems and NCR VoyixDirector2024YesAudit (chair)67
Molly JosephDirectorIndependent · since 2021 · Compensation (chair), Nominating and Corporate GovernanceFormer Chief Executive Officer, UnitedHealthcare GlobalOther boards: Lumexa Imaging, Inc.Director2021YesCompensation (chair), Nominating and Corporate Governance52
Deborah L. KellerDirectorIndependent · since 2017 · Nominating and Corporate Governance (chair), CompensationFormer Chief Executive Officer, Covance Drug DevelopmentDirector2017YesNominating and Corporate Governance (chair), Compensation63
Goldman Myla LaiDirectorDirector
Myla P. Lai-Goldman, M.D.DirectorIndependent · since 2014 · AuditChair & Former Chief Executive Officer & President, GeneCentric Therapeutics, Inc.Other boards: Quanterix CorporationDirector2014YesAudit68
Stephen H. LockhartDirectorDirector
Stephen H. Lockhart, M.D., Ph.D.DirectorIndependent · since 2022 · CompensationFormer Chief Medical Officer, Sutter HealthOther boards: Molina Healthcare and National Research Corporation HealthDirector2022YesCompensation67
Douglas A. MichelsDirectorIndependent · since 2011 · Audit, Nominating and Corporate GovernanceRetired President & Chief Executive Officer, OraSure Technologies, Inc.Director2011YesAudit, Nominating and Corporate Governance69
Paolo PucciDirectorIndependent · since 2016 · AuditRetired Chief Executive Officer, ArQule, Inc.Other boards: Replimune Group Inc.Director2016YesAudit64
Officers (8)
Robert W. McMahonSVP & Chief Financial OfficerLast filed 12 Aug 2026SVP & Chief Financial Officer
Shane Alden CampbellSVP, Proprietary SegmentLast filed 14 May 2026SVP, Proprietary Segment
Annette F. FavoriteSr. VP & Chief HR OfficerLast filed 15 Sep 2026Sr. VP & Chief HR Officer
Norman D. Finch Jr.SVP, GC & Corporate SecretaryLast filed 3 Mar 2026SVP, GC & Corporate Secretary
Michel LagardePresident and CEOAlso at Vertex PharmaceuticalsLast filed 10 Sep 2026President and CEO
Rodolphe Jean PoussotSVP, Strategy & Corporate DevLast filed 3 Mar 2026SVP, Strategy & Corporate Dev
Chad WintersVP, Chief Accounting OfficerLast filed 29 Apr 2026VP, Chief Accounting Officer
Charles WitherspoonVP & TreasurerLast filed 23 Feb 2026VP & Treasurer

Companies that share people with West Pharmaceutical Services

Each person's title here, then at the other company.

  • Ecolab ECL
    • Eric Mark Green: Chair and CEO here, Director there
  • IDEX IEX
    • Mark A. Buthman: Director here, Director there
  • Vertex Pharmaceuticals VRTX
    • Michel Lagarde: President and CEO here, Director there
  • Xylem XYL
    • Robert F. Friel: Lead Independent Director here, Chair there

Owners and trading

Largest institutional holders

Each fund group's share of West Pharmaceutical Services. Where a company has several share classes, the share is of its total value.

13F filings for the quarter to 30 Jun 2026

These five hold 35.9% of West Pharmaceutical Services.

Insider trades

Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.

Trades from 10 Nov 2025 to 10 Nov 2026

Directors and officers sold $6.6 million of stock in 6 sales and made no open-market purchases in the 12 months to 10 Nov 2026.

DatePersonTitleTypeSharesValue
15 Sep 2026SaleAnnette F. FavoriteSr. VP & Chief HR OfficerSr. VP & Chief HR OfficerSale2,524$921K
14 Sep 2026SaleAnnette F. FavoriteSr. VP & Chief HR OfficerSr. VP & Chief HR OfficerSale2,500$888K
11 Sep 2026SaleAnnette F. FavoriteSr. VP & Chief HR OfficerSr. VP & Chief HR OfficerSale2,500$863K
8 Sep 2026SaleAnnette F. FavoriteSr. VP & Chief HR OfficerSr. VP & Chief HR OfficerSale8,135$2.8M
27 Apr 2026SaleAnnette F. FavoriteSr. VP & Chief HR OfficerSr. VP & Chief HR OfficerSale2,817$860K
27 Apr 2026SaleChad WintersVP, Chief Accounting OfficerVP, Chief Accounting OfficerSale896$269K

Trades by members of Congress and officials

Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.

Trades from 30 Oct 2023 to 30 Oct 2026

6 people disclosed 8 purchases and 8 sales of West Pharmaceutical Services stock since October 2023.

DateMember or officialTypeAmount
30 Jan 2026Arjun Mody (Deputy Commissioner)Deputy Commissioner · SoldSale$1,001 to $15,000$1K to $15K
29 Jan 2026Rohit Khanna (House, D-CA)House, D-CA · BoughtPurchase$1,001 to $15,000$1K to $15K
22 Jul 2025Lisa McClain (House, R-MI)House, R-MI · SoldSale$1,001 to $15,000$1K to $15K
17 Jun 2025Lisa McClain (House, R-MI)House, R-MI · BoughtPurchase$1,001 to $15,000$1K to $15K
9 Jun 2025Stephen I Miran (Governor)Governor · SoldSale$15,001 to $50,000$15K to $50K
19 May 2025Rohit Khanna (House, D-CA)House, D-CA · BoughtPurchase$1,001 to $15,000$1K to $15K
23 Apr 2025Rohit Khanna (House, D-CA)House, D-CA · BoughtPurchase$1,001 to $15,000$1K to $15K
8 Apr 2025Rob Bresnahan (House, R-PA)House, R-PA · SoldSale$1,001 to $15,000$1K to $15K
12 Mar 2025Rohit Khanna (House, D-CA)House, D-CA · SoldSale$1,001 to $15,000$1K to $15K
25 Feb 2025Rob Bresnahan (House, R-PA)House, R-PA · BoughtPurchase$1,001 to $15,000$1K to $15K

Showing 10 of 16 trades

Workforce and hiring

Workforce

Headcount at 31 Dec 2025

Employees
10,800

Employees, last 10 fiscal years

Up 17% in five years, from 9,200 in 2020 to 10,800 in 2025.

As of December 31, 2025, we employed approximately 10,800 people, excluding contractors and temporary workers, in our operations throughout the world.
West Pharmaceutical Services Form 10-K

Open roles

Jobs listed on West Pharmaceutical Services' careers site, each counted once.

Daily, up to 10 Nov 2026

Open roles
246
On 10 Nov 2026
Change
+14
Up 6.0% since 3 Nov 2026
Top function
Operations & Supply Chain
59% of open roles
Remote
0%
24% do not say

Open roles in detail

27 Oct 2026 to 10 Nov 2026

27 Oct10 Nov246

WARN layoff notices

Notices filed under West Pharmaceutical Services' own name or a subsidiary's listed in its 10-K.

Notices from 12 Nov 2023 to 12 Nov 2026

West Pharmaceutical Services filed 1 notice covering 98 workers since November 2023.

NoticePlaceWorkersEffective
3 Sep 2026Scottsdale, AZ98-

Timeline

Leadership changes, layoffs and insider sales

12 Nov 2024 to 12 Nov 2026; insider sales from 10 Nov 2025

5 departures and 7 appointments of directors and officers, WARN layoff notices on 1 day and 1 large insider sale in the last two years.

Left the company or board 5Appointed 7WARN layoff notices 1Large insider sales 1Jan 2025AprJulOctJan 2026AprJulOct

Insider sales of $1 million or more, and the largest tenth of West Pharmaceutical Services' insider sales.

Events, newest first

Showing 8 of 14 events